ANTH — Anthera Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Anthera Pharma's Board Approves Personnel Reorganization Plan
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, Netflix, BlueLinx, Micron
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, BlueLinx, Orexigen, Micron
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, Orexigen, Goldman
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Broadcom, Orexigen, Quidian, Egalet Corp
Anthera to explore options after lead drug fails trial, shares slump (updated)
Anthera Pharma: Set to open at record low after lead drug fails study
NASDAQ RESUMED
Anthera to explore options after lead drug's trial failure
NASDAQ TRADE HALT HALT NEWS PENDING
U.S. STOCKS ON THE MOVE-Abercrombie, Carvana, Autodesk, Dollar Tree
Brief: Anthera Pharma Files For Mixed Shelf Of Up To $100 Million
Brief: Anthera Pharma Qtrly Net Loss Per Share Applicable To Common Stockholders $0.73
What to Watch in the Week Ahead and on Monday, January 29
Brief: Anthera Receives Positive Nasdaq Listing Determination
Brief: Anthera Announces Positive Outcome Of Second Interim Futility Analysis In The Phase 3 Sollpura Study
Brief: 683 Capital Management Reports 6.1 Pct Passive Stake In Anthera Pharma
Brief: Anthera Pharma Appoints Patrick Murphy As Senior Vice President, Manufacturing
Brief: Anthera Pharmaceuticals Announces Positive Outcome In The Phase 3 Result Clinical Study Of Sollpura